Page last updated: 2024-09-04

rhodioloside and Focal Segmental Glomerulosclerosis

rhodioloside has been researched along with Focal Segmental Glomerulosclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
He, L; Liu, G	1

Other Studies

1 other study(ies) available for rhodioloside and Focal Segmental Glomerulosclerosis

Article	Year
Salidroside Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis by Inhibiting the Hypoxia-Inducible Factor-1α Expression Through Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway. Nephron, 2019, Volume: 142, Issue:3 Topics: Animals; Doxorubicin; Glomerulosclerosis, Focal Segmental; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred C57BL; Oxidative Stress; Phenols; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction	2019

Article

Year

Salidroside Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis by Inhibiting the Hypoxia-Inducible Factor-1α Expression Through Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway.

Nephron, 2019, Volume: 142, Issue:3

Topics: Animals; Doxorubicin; Glomerulosclerosis, Focal Segmental; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Mice, Inbred C57BL; Oxidative Stress; Phenols; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction

2019